ACAD Sales/Maturities of Investments

Acadia Pharmaceuticals Inc · Sales/Maturities of Investments

ACAD logo

ACAD Sales/Maturities of Investments

Latest reported$494.34M
ACAD Sales/Maturities of Investments ($0.00 → $494.34M)
High-resolution chart · PNG

ACAD sales/maturities of investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Acadia Pharmaceuticals Inc Sales/Maturities of Investments — Annual fiscal periods (USD)
Period endingSales/Maturities of Investments (USD)
493,529,000
328,565,000
442,033,000
436,415,000
422,817,000
540,004,000
413,927,000
261,678,000
572,103,000
430,937,000
419,197,000
248,268,000
86,087,000
30,948,000
54,049,000
53,486,000
59,750,000
149,912,000
180,745,000
83,166,000
48,893,000
29,853,000
24,150,000
16,221,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.